Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInt.biotech. Share News (IBT)

Share Price Information for Int.biotech. (IBT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 664.00
Bid: 660.00
Ask: 668.00
Change: 6.00 (0.91%)
Spread: 8.00 (1.212%)
Open: 662.00
High: 672.00
Low: 662.00
Prev. Close: 658.00
IBT Live PriceLast checked at -
International Biotechnology is an Investment Trust

To achieve capital growth through investing in high growth, development stage biotechnology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares

Tue, 02nd Nov 2021 15:20

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

MJ Gleeson PLC - Sheffield, England-based housebuilder - Mark Knight, managing director of Gleeson Homes, buys 18,795 shares at GBP7.94, worth GBP149,232, on Monday. Knight now has 33,682 shares, a 0.1% stake.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Non-Executive Chair Bill Russell buys 8,200 shares at USD12.37, worth USD101,393, in the US on Friday last week. Now has 53,507 shares, a 0.1% stake.

----------

Riverstone Credit Opportunities Income PLC - aims to generate returns by making loans to companies in energy sector - Director Reuben Jeffery buys 50,000 shares at USD0.86, worth USD43,130, on Monday.

----------

International Biotechnology Trust PLC - investment trust run by SV Health Managers LLP - Non-Executive Director Patrick Magee buys 4,000 shares at 735 pence, worth GBP29,400, on Tuesday. Now has 7,500 shares.

----------

Headlam Group PLC - Birmingham-based floorcoverings distributor - Independent Non-Executive Director Stephen Bird buys 5,000 shares at 462.60p, worth GBP23,130, on Monday.

----------

Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 19 pence, worth about GBP19,000, on Friday last week. Vulpes now has 117.3 million shares, a 14.4% stake.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.